NCT06677047

Brief Summary

This study aims to explore the effects of exercise rehabilitation on the functional status of patients with pulmonary fibrosis, assessing both physical and psychological dimensions of health. By identifying significant improvements, we can contribute to the development of comprehensive rehabilitation strategies that enhance patient outcomes and foster a better quality of life for those affected by this challenging condition

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 5, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 6, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

January 20, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 20, 2025

Completed
Last Updated

November 6, 2024

Status Verified

October 1, 2024

Enrollment Period

5 months

First QC Date

November 5, 2024

Last Update Submit

November 5, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • **Asses Health-Related Quality of Life:**

    Assessed through validated questionnaires such as the St. George's Respiratory Questionnaire (SGRQ)

    Baseline

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

\*\*Demographic Data Collection:\*\* * Age, sex, duration of pulmonary fibrosis, and medical history. 2\. \*\*Pulmonary Function Testing:\*\* * Spirometry will be conducted to assess Forced Vital Capacity (FVC) and Forced Expiratory Volume in one second (FEV1). 3\. \*\*Functional Capacity Assessment:\*\* * The Six-Minute Walk Test (6MWT) will be performed to evaluate baseline exercise tolerance. 4\. \*\*Quality of Life Evaluation:\*\* * Health-related quality of life will be assessed using the St. George's Respiratory Questionnaire (SGRQ) or Chronic Respiratory Disease Questionnaire (CRQ). 5\. \*\*Dyspnea Assessment:\*\* * Dyspnea levels will be measured using the Modified Medical Research Council (mMRC) dyspnea scale. * Exercise Rehabilitation Program Participants will engage in a structured 8-week exercise rehabilitation program, which includes: * \*\*Supervised Exercise Sessions:\*\* * Participants will attend twice-weekly sessions led by trained physiotherapists, focusing on aerobic

You may qualify if:

  • \. \*\*Diagnosis of Pulmonary Fibrosis:\*\*
  • Patients must have a confirmed diagnosis of pulmonary fibrosis, as determined by clinical evaluation and imaging studies (e.g., high-resolution computed tomography).
  • \. \*\*Age Range:\*\*
  • Participants should be adults aged 18 years and older to capture the adult population affected by the disease.
  • \. \*\*Stable Clinical Condition:\*\*
  • Patients must be in a stable clinical condition, defined as no exacerbations or significant changes in treatment for at least four weeks prior to enrollmen

You may not qualify if:

  • \. \*\*Other Significant Lung Diseases:\*\*
  • Patients with concurrent respiratory conditions (e.g., chronic obstructive pulmonary disease, asthma, or lung cancer) that could confound the results.
  • \. \*\*Acute Exacerbations:\*\*
  • Individuals experiencing an acute exacerbation of pulmonary fibrosis or any significant respiratory illness within four weeks prior to enrollment.
  • \. \*\*Severe Comorbidities:\*\*
  • Patients with severe cardiovascular disease, uncontrolled hypertension, major neurological disorders, or musculoskeletal problems that would impede participation in exercise.
  • \. \*\*Cognitive Impairment:\*\*
  • Individuals with cognitive impairments that prevent them from understanding the study procedures or following the rehabilitation program.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Troosters T, Janssens W, Demeyer H, Rabinovich RA. Pulmonary rehabilitation and physical interventions. Eur Respir Rev. 2023 Jun 7;32(168):220222. doi: 10.1183/16000617.0222-2022. Print 2023 Jun 30.

Central Study Contacts

Hend Mohamed Sayed, Doctor

CONTACT

Ahmed mohamed Shadad, Doctor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

November 5, 2024

First Posted

November 6, 2024

Study Start

January 20, 2025

Primary Completion

June 20, 2025

Study Completion

August 20, 2025

Last Updated

November 6, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share